Disintegrin variants and uses thereof
US11202854B2 · kind B2 · utility
0Cited by
0References
13Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Aug 9, 2017 |
| Grant date | Dec 21, 2021 |
| Priority date | — |
| Expiry date | Feb 16, 2038 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61L2420/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed herein are disintegrin variants, and methods for suppressing or inhibiting platelet aggregation in a subject in need thereof. The method includes administering to the subject in need thereof an effective amount of the present disintegrin variant to alleviate or ameliorate symptoms associated with diseases, disorders, and/or conditions resulted from platelet aggregation. According to preferred embodiments, the present disintegrin variant is applied as a coating on an implantable device, such as a stent or a catheter.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.